Renal artery calcium is independently associated with hypertension.
We tested the hypothesis that renal artery calcium (RAC), a marker of atherosclerotic plaque burden, is also significantly associated with higher blood pressure levels and a diagnosis of hypertension. In the nonrenal systemic vasculature, atherosclerotic plaque burden has been shown to be significantly associated with hypertension. A total of 1,435 consecutive patients were evaluated at a university-affiliated disease prevention center for the extent of calcified atherosclerosis in the systemic vasculature. The overall prevalence of calcium in either renal artery was 17.1%, with men having a significantly higher prevalence (19.0%, 153 of 804) than women (14.7%, 93 of 631) (p = 0.03). After adjustment for age and gender, subjects with a RAC score >0 had a significantly higher prevalence of hypertension (41.2 vs. 29.5, p < 0.01). In a logistic model that adjusted for age, gender, body mass index, percent body fat, diabetes, smoking, dyslipidemia, and the extent of calcified atherosclerosis in the nonrenal vasculature, those with any RAC had a significantly higher odds ratio (1.61, p = 0.01) for hypertension than those with no RAC. The results of this study suggest that the presence of RAC is associated with higher odds for prevalent hypertension, independent of CVD risk factors and the extent of calcified atherosclerosis in the nonrenal vasculature.